Preferences for albumin use in adult intensive care unit patients with shock: An international survey
- PMID: 39302760
- DOI: 10.1111/aas.14479
Preferences for albumin use in adult intensive care unit patients with shock: An international survey
Erratum in
-
Correction to "Preferences for albumin use in adult intensive care unit patients with shock: An international survey".Acta Anaesthesiol Scand. 2025 Jan;69(1):e14557. doi: 10.1111/aas.14557. Acta Anaesthesiol Scand. 2025. PMID: 39651866 No abstract available.
Abstract
Introduction: Use of albumin is suggested for some patients with shock, but preferences for its use may vary among intensive care unit (ICU) physicians.
Methods: We conducted an international online survey of ICU physicians with 20 questions about their use of albumin and their opinion towards a randomised trial among adults with shock comparing the use versus no use of albumin.
Results: A total of 1248 respondents participated, with a mean response rate of 37%, ranging from 18% to 75% across 21 countries. Respondents mainly worked in mixed ICUs and 92% were specialists in intensive care medicine. The reported use of albumin in general shock varied as 18% reported 'almost never', 22% 'rarely', 34% 'occasionally', 22% 'frequently' and 4% 'almost always' using albumin. In septic shock, 19% reported 'almost never', 22% 'rarely', 29% 'occasionally', 22% 'frequently' and 7% 'almost always' using albumin. Physicians' preferences were more consistent for haemorrhagic- and cardiogenic shock, with more than 45% reporting 'almost never' using albumin. While the reported use of albumin for other purposes than resuscitation was infrequent (40%-85% reported 'almost never' for five other indications), the most frequent other indications were low serum albumin levels and improvement of the efficacy of diuretics. Most respondents (93%) would randomise adult ICU patients with shock to a trial of albumin versus no albumin.
Conclusions: In this international survey, the reported preferences for the use of albumin in adult ICU patients with shock varied considerably among surveyed ICU physicians. The support for a future randomised trial was high.
Keywords: albumin; fluid therapy; intensive care unit; shock; survey.
© 2024 The Author(s). Acta Anaesthesiologica Scandinavica published by John Wiley & Sons Ltd on behalf of Acta Anaesthesiologica Scandinavica Foundation.
References
REFERENCES
-
- Vincent JL, De Backer D, Wiedermann CJ. Fluid management in sepsis: the potential beneficial effects of albumin. J Crit Care. 2016;35:161‐167.
-
- Vincent JL, Russell JA, Jacob M, et al. Albumin administration in the acutely ill: what is new and where next? Crit Care. 2014;18(4):231.
-
- Saner FH, Stueben BO, Hoyer DP, Broering DC, Bezinover D. Use or misuse of albumin in critical ill patients. Diseases. 2023;11(2):68.
-
- Mårtensson J, Bihari S, Bannard‐Smith J, et al. Small volume resuscitation with 20% albumin in intensive care: physiological effects: the SWIPE randomised clinical trial. Intensive Care Med. 2018;44(11):1797‐1806.
-
- Orbegozo Cortés D, Gamarano Barros T, Njimi H, Vincent JL. Crystalloids versus colloids: exploring differences in fluid requirements by systematic review and meta‐regression. Anesth Analg. 2015;120(2):389‐402.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources

